Characterization of leukocyte subtypes in chicken inner ear sensory epithelia.
Human hearing and balance require intact inner ear sensory hair cells, which transduce mechanical stimuli into electrical signals that are transmitted to the brain. Loss of hair cells after birth in mammals is irreversible, whereas birds are able to regenerate hair cells after insult and demonstrate ongoing hair cell production in the vestibular epithelia. Leukocytes reside in undamaged sensory epithelia of the avian inner ear and increase in number after trauma, prior to the proliferation of hair cell progenitors. It has been hypothesized that leukocyte-produced growth factors or cytokines may be involved in triggering hair cell regeneration. Little is known about the specific leukocyte subtypes present in avian ear. Immunohistochemistry with a panel of monoclonal antibodies to chicken leukocytes was used to identify leukocyte subtypes in normal posthatch chicken ear sensory epithelia. The responsiveness of the leukocytes to aminoglycoside-induced damage was also observed. Based on immunocytochemical and morphological criteria, we quantified leukocyte subtypes in normal and drug-damaged auditory and vestibular sensory epithelia. Data indicate that lymphocytes (B and T cells) do not reside in normal or drug-damaged ear sensory epithelia at 1-3 days post insult but are present in adjacent nonsensory tissues. The most common leukocytes in inner ear sensory epithelia are ramified cells of the myeloid lineage. Many of these are MHC class II positive, and a small percentage are mature tissue macrophages. An absence of leukocytes in lesioned areas of the auditory sensory epithelium suggests they may not play a critical role in triggering hair cell regeneration.
O'Halloran
Elizabeth K
EK
Virginia Merrill Bloedel Hearing Research Center, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, Washington 98195-7923, USA.
Oesterle
Eliazabeth C
EC
D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D000900:Anti-Bacterial Agents / Q000633:toxicity; D000954:Antigens, Surface / Q000378:metabolism; D001973:Bromodeoxyuridine / Q000378:metabolism; D017252:CD3 Complex / Q000378:metabolism; D002452:Cell Count; D002645:Chickens; D007758:Ear, Inner / Q000166:cytology* / Q000187:drug effects; D004848:Epithelium / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D005839:Gentamicins / Q000633:toxicity; D006023:Glycoproteins / Q000378:metabolism; D018069:Hair Cells, Vestibular / Q000187:drug effects / Q000473:pathology; D007150:Immunohistochemistry / Q000379:methods; D007962:Leukocytes / Q000145:classification* / Q000187:drug effects / Q000378:metabolism; D024101:Mitochondrial Proteins; D016692:Receptors, Antigen, T-Cell, gamma-delta / Q000378:metabolism; D012444:Saccule and Utricle / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D018709:Statistics, Nonparametric; D013307:Streptomycin / Q000633:toxicity; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000954:Antigens, Surface; D017252:CD3 Complex; D005839:Gentamicins; D006023:Glycoproteins; D024101:Mitochondrial Proteins; D016692:Receptors, Antigen, T-Cell, gamma-delta; C031044:insulin-dependent cytoplasmic regulator protein, rat; D001973:Bromodeoxyuridine; D013307:Streptomycin